Innovent announces first-time inclusion of Sintbilo and new indication for olverembatinib in China’s National Reimbursement Drug List: San Francisco, US Friday, November 29, 202 ...
Cardiovascular diseases remain a leading cause of mortality globally, particularly among individuals with both obstructive sleep apnea (OSA) and metabolic syndrome (MetS).
Comfort eating to cheer ourselves up is nothing new but it’s recently escalated among Millennials and Gen Zs. As negative political and economic news escalates on both sides of the Pond, ‘doom eating’ ...
Associations between sleep and CVD risk factors vary by sex. While more N3 sleep results in lower BP in women, more wake after sleep onset results in higher BP in men.